Biotech Values

[mcbio]

Re: BioMS

"How plausible is it that Dirucotide has strong efficacy in SPMS but not in RRMS?"

That's a very good question and one I meant to raise in my last post but forgot. I am by no means an MS expert so I don't know all of the differences/similarities between those two patient populations (SPMS vs. RRMS) and how a given drug should react in those two populations. But, it's another fair question that has to raise some level of doubt for the drug.